PRODUÇÃO ACADÊMICA Repositório Acadêmico da Graduação (RAG) TCC Medicina
Use este identificador para citar ou linkar para este item: https://repositorio.pucgoias.edu.br/jspui/handle/123456789/3745
Registro completo de metadados
Campo DCValorIdioma
dc.creatorAyres, Celina Kalena Albuquerque Amorim-
dc.creatorOliveira, Maize Lúcia de-
dc.date.accessioned2022-05-30T14:30:14Z-
dc.date.available2022-05-30T14:30:14Z-
dc.date.issued2022-05-26-
dc.identifier.urihttps://repositorio.pucgoias.edu.br/jspui/handle/123456789/3745-
dc.description.abstractObjective: To present scientific evidence to the possibility of SARS-CoV-2 infection in Newborns (NB) by vertical transmission and to describe the main maternal, fetal and neonatal complications. Bibliographic Review: During gestation, SARS-CoV-2 infection can negatively affect pregnancy, since it increases the obstetric morbidity, the occurrence of preterm birth and the premature rupture of the membrane, which has repercussions on hospitalizations of neonates in intensive care unit (ICU). Given this fact, pregnant women are considered a group of risk to develop maternal and fetal complications from the diagnosis of COVID-19 during pregnancy. Final considerations: The main maternal-fetal complications of this infection include premature birth, miscarriage, preeclampsia, pneumonia, fetal prematurity, intrauterine fetal distress, low birth weight, neonatal asphyxia, perinatal death and stillbirth. As it is a still unknown pathology, emerging studies are needed to identify and early reduce its risks during pregnancy exposure to SARS-CoV-2, as well as to guide pregnant women during prenatal care.pt_BR
dc.description.sponsorshipNão recebi financiamentopt_BR
dc.languageporpt_BR
dc.publisherPontifícia Universidade Católica de Goiáspt_BR
dc.relationNão se aplicapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectCovid-19pt_BR
dc.subjectTransmissão verticalpt_BR
dc.subjectDiagnósticopt_BR
dc.subjectGestaçãopt_BR
dc.subjectPandemiapt_BR
dc.titlePossibilidades da transmissão vertical da Covid-19 e as principais complicações materno-fetais e neonatais: uma revisão da literaturapt_BR
dc.typeTrabalho de Conclusão de Cursopt_BR
dc.contributor.advisor1Rocha Sobrinho, Hermínio Maurício da-
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/5573574130526137pt_BR
dc.contributor.referee1Gigonzac, Marc Alexandre Duarte-
dc.contributor.referee1Latteshttp://lattes.cnpq.br/5243589379211142pt_BR
dc.contributor.referee2Quixabeira, Valéria Bernadete Leite-
dc.contributor.referee2Latteshttp://lattes.cnpq.br/5995196506303951pt_BR
dc.description.resumoObjetivo: Apresentar evidências científicas da possibilidade de infecção por SARS-CoV-2 em Recém-Nascidos (RN) via transmissão vertical e descrever as principais complicações maternas, fetais e neonatais. Revisão Bibliográfica: Durante a gestação, a infecção pelo SARS-CoV-2 pode afetar negativamente a gravidez, uma vez que aumenta a morbidade obstétrica, a ocorrência de parto prematuro e a ruptura prematura da membrana que repercute em internações de neonatos em Unidades de Terapia Intensiva (UTI). Diante deste fato, as gestantes são consideradas grupos de risco para desenvolverem complicações maternas e fetais a partir do diagnóstico da COVID-19 durante a gravidez. Considerações finais: As principais complicações materno-fetais desta infecção incluem parto prematuro, aborto espontâneo, pré-eclâmpsia, pneumonias, prematuridade fetal, sofrimento fetal intrauterino, baixo peso ao nascer, asfixia neonatal, morte perinatal e natimorto. Por se tratar de uma patologia ainda desconhecida, necessita-se de estudos emergentes capazes de identificar e diminuir precocemente os seus riscos durante a exposição da gravidez ao SARS-CoV-2, bem como, de orientar as gestantes durante o pré-natal.pt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentEscola de Ciências Médicas e da Vidapt_BR
dc.publisher.initialsPUC Goiáspt_BR
dc.subject.cnpqCNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::GINECOLOGIA E OBSTETRICIApt_BR
dc.relation.references1. AATIF M, et al. Vertical transmission of corona virus-possibly first case from Pakistan. Pakistan Armed Forces Medical Journal, 2020; 70(1): S427-429. 2. ALZAMORA MC, et al. Severe COVID-19 during Pregnancy and Possible Vertical Transmission. American Journal of Perinatology, 2020; 37(8): 861–865. 3. BENVENUTO D, et al. The 2019‐new coronavirus epidemic: evidence for virus evolution. Journal of Medical Virology, 2020; 92 (4) 455-459. 4. DASHRAARH P, et al. Special Report and pregnancy. American Journal of Obstetrics e Gynecology, 2020; 222 (6): 521–531. 5. DI MASCIO D, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology, 2020; 2(2): 100107. 6. EDLOW AG, et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Network Open, 2020; 3(12): e2030455. 7. EGLOFF C, et al. Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2. Journal of Clinical Virology,2020; 128: 104447. 8. FENIZIA C, et al. Analysis of sars-cov-2 vertical transmission during pregnancy. Nature Communications, 2020; 11(1):1-10. 9. SOARES RA, GAUDARD AMIS. Transmissão vertical do SARS-CoV-2: uma revisão sistemática. Brazilian Journal of Health Review, 2020; 3(3): 4236-4240 10. GONZÁLEZ-MESA E, et al. Transmitted Fetal Immune Response in Cases of SARS-CoV-2 Infections during Pregnancy. Diagnostics (Basel), 2022; 12(2): 245. 11. GORBALENYA A, et al. Severe acute respiratory syndrome-related corona virus: The species and its viruses – a statement of the Coronavirus Study Group. BioRxiv, 2020; 1-15. 12. HOSIER H, et al. SARS–CoV-2 infection of the placenta. The Journal of Clinical Investigation, 2020; 130(9): 4947–4953 13. HSU A, et al. Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease. Journal of Medical Virology, 2021; 93. 14. JUAN J, et al. Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal, and neonatal outcome: systematic review. Ultrasound in Obstetrics & Gynecology, 2020; 56(1): 15-27. 15. KHAN S, et al. Association of COVID-19 with pregnancy outcomes in health-care workers and general women. Clinical Microbiology and Infection, 2020; 26: 788-90. 16. KARIMI-ZARCHI M, et al. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review. Fetal and Pediatric Pathology, 2020; 39(3): 246–250 17. KITAJIMA H, et al. Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR). Journal of Clinical Virology, 2021; 139: 104813. 18. KONSTANTINIDOU A, et al. Pharyngeal sampling for PCR-testing in the investigation of SARS-COV-2 vertical transmission in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021; 260: 18-21. 19. LAUREANO AFS, RIBOLDI M. The different tests for the diagnosis of COVID-19 - A review in Brazil so far. JBRA Assisted Reproduction, 2020; 24(3): 340–346. 20. LI M, et al. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLOS ONE, 2020; 15(4): e0230295. 21. MOREIRA LMO, et al. SARS-CoV-2 infection in pregnant women and newborns in two maternity hospitals in Salvador Bahia, Brazil. The Brazilian Journal of Infectious Diseases, 2021; 25: 101591. 22. NIE R, et al. Clinical features and the maternal and neonatal outcomes of pregnant women with coronavirus disease. MedRxiv, 2020; 27. 23. ONG DSY, et al. How to interpret and use COVID-19 serology and immunology tests. Clinical Microbiology and Infection, 2021; 27(7): 981-986. 24. PEREZ OM, et al. A associação entre infecção por SARS-CoV-2 e parto prematuro: um estudo prospectivo com análise multivariável. BMC Pregnancy Childbirth, 2021; 21, 273. 25. PETTIROSSO E, et al. COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes, and vertical transmission. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2020; 60: 640-659. 26. RAMIRO NCMP, et al. Repercussões fetais e possíveis complicações da COVID-19 durante a gestação. Revista Saúde Coletiva, 2020; 10(54): 2679-.2690. 27. ROTHAN HA, BYRAREDDY SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 2020; 109: 102433. 28. SALEM D, et al. COVID-19 infection in pregnant women: Review of maternal and fetal outcomes. International Journal of Gynecology and Obstetrics, 2021; 152(3): 291-298.Revista Eletrônica Acervo Saúde | ISSN 2178-2091 REAS | Vol.15(5) | DOI: https://doi.org/10.25248/REAS.e10173.2022 Página 11 de 11 29. SELIM M, et al. Is COVID-19 Similar in Pregnant and Non- Pregnant Women?. Cureus, 2020; 12(6): 19–21. 30. SCHWARTZ DA, et al. Confirming Vertical Fetal Infection With Coronavirus Disease 2019: Neonatal and Pathology Criteria for Early Onset and Transplacental Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From Infected Pregnant Mothers. Archives of Pathology & Laboratory Medicine, 2020; 144 (12): 1451–1456. 31. SHENDE P, et al. Persistence of SARS-CoV-2 in the first trimester placenta leading to transplacental transmission and fetal demise from an asymptomatic mother. Human Reproduction, 2021; 36(4): 899–906. 32. SHEREEN M, et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 2020; 24: 91-98. 33. SOHEILI M, et al. Clinical manifestation and maternal complications and neonatal outcomes in pregnant women with COVID-19: a comprehensive evidence synthesis and meta-analysis. Journal of Maternal-Fetal and Neonatal Medicine, 2021; 1 –14. 34. VIVANTI AJ, et al. Transplacental transmission of SARS-CoV-2 infection. Nature Communications, 2020; 11(1): 1-7. 35. WASTNEDGE EAN, et al. Pregnancy and COVID-19. Physiological Reviews, 2021; 101(1): 303–318. 36. ZENG L, et al. Neonatal Early-Onset Infection with SARS-CoV-2 in 33 Neonates Born to Mothers with COVID-19 in Wuhan, China. JAMA Pediatrics – The Science of Child and Adolescent Health, 2020; 174(7): 722–725. 37. CRUZ NAN, et al. Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients. Frontiers in Physiology, 2021. 12: 1-13 38. FURQAANI AR, YULIANTI AB. Literature Review: Transplacental Transmission of COVID-19 and Its Teratological Aspect. RSF Conference Series: Medical and Health Science, 2021; 1(1): 106-111. 39. EL-ARABEY AA, MOHNAD A. Transplacental transmission of SARS-CoV-2 infection via NRP1. Travel Medicine and Infectious Disease, 2021. 40(101987): 1-2. 40. MAHYUDDIN AP, et al. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s. Prenatal diagnosis, 2020; 40(13): 1655-1670pt_BR
dc.degree.graduationMedicinapt_BR
dc.degree.levelGraduaçãopt_BR
Aparece nas coleções:TCC Medicina

Arquivos associados a este item:
Arquivo TamanhoFormato 
Ayres et al 2022_Transmissão vertical da covid19.pdf599,78 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.

Ferramentas do administrador